$INO $INO Something to think about before anyone decides to sell away your shares. FDA may place a current hold on p2/3; the question concerning the Cellectra 3PSP device has nothing to do with INO-4800. The Cellectra 3PSP leverages aspects of the Cellectra 2000, which is an earlier version of the 3PSP. It operates on AA batteries and they can be stockpiled in large quantities without special maintenance. On Sept. 8, Thermo Fisher Scientific signed a letter of intent to manufacture INO-4800. Additionally, the Cellectra device already began last summer with $8.1 million in funding from the U.S. Defense Threat Reduction Agency’s Medical CBRN Defense Consortium. Why? The U.S. Defense Threat Reduction Agency’s Medical CBRN Defense Consortium is also developing a DNA vaccines and want to collaborate with INO on the use of the Cellectra 3PSP device inconjunction with their vaccines. Hmmmm....in time the world will know a whole lot more. bioworld.com/articles/49827...
  • 13
13 Likes